These results are consistent with the findings of a systematic review by Fenton et al,13 which concluded that an increased diagnostic activity (the introduction of PSA screening) reduced prostate cancer mortality but was associated with overdiagnosis and possibly overtreatment.1 This evidence concerns the gene KLK3 and prostate cancer.